A fully funded 3 years post-doctoral position is available in Terzi Lab to explore the role of a renal specific transcription factor in the progression of chronic kidney disease progression. The successful candidate will join a dynamic and collaborative team to work on cutting-edge research that has the potential to uncover new therapeutic strategies.

The LRCB (KU Leuven) is interested in studying RNA metabolism in cancer. In particular, we aim at characterising long non-coding RNAs important for cancer progression. Towards this we apply cutting edge molecular biology and biochemistry techniques coupled to in vivo and ex vivo preclinical studies, with the ultimate goal of identifying promising therapeutic targets. The laboratory hosts also Trace, a state-ofthe- art facility offering a unique collection of >150 well-annotated patient-derived models, belonging to 11 tumour types. KU Leuven is an exciting, interdisciplinary university hosting excellent facilities and research groups and providing extensive opportunities for training.

The launch of IRIBHM Jacques E. Dumont’s 2025 International PhD Programme—a unique opportunity designed to prepare the next generation of leaders in biomedical sciences. With several fellowships available, successful candidates will dive into cutting-edge research projects in a warm, collaborative environment held to the highest international standards.

The Master’s program, lasting one year, is structured around live online lectures conducted synchronously, two workshops, a 300-hour internship, and a final examination. Specifically, the program includes four traditional teaching courses delivered through lectures and one alternative teaching course in the form of practical exercises.

1-year postdoc position in my lab (vaccarilab.unimi.it) at the Department of Biosciences of the University of Milan. We study lysosomes and autophagy in fly models of rare disease. We use a combination of genetic, imaging and biochemical approaches and quantitative phenotypic assessments.